lunes, 29 de enero de 2024

FDA revises letter of authorization for the emergency use authorization for Paxlovid

https://www.fda.gov/drugs/drug-safety-and-availability/fda-revises-letter-authorization-emergency-use-authorization-paxlovid?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario